Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, dated October 2, 2025, reports on a specific corporate action regarding the company's share buyback programme. Haleon is a global leader in consumer health with a portfolio spanning oral health, vitamins, pain relief, respiratory health, digestive health, and therapeutic skin health.
Key Financial Metrics and Transaction Details
The filing details the purchase of 1,561,229 ordinary shares under the second tranche of the buyback programme announced on July 31, 2025. The transaction occurred on October 1, 2025, across the London Stock Exchange and CBOE (UK) venues.
| Metric | Value |
|---|---|
| Shares Purchased | 1,561,229 |
| Highest Price Paid | 337.50 pence |
| Lowest Price Paid | 331.90 pence |
| Volume Weighted Average Price | 335.07 pence |
| Treatment of Shares | Held as treasury shares |
Following this transaction, the company's registered share capital stands at 8,952,353,648 ordinary shares. Of these, 45,962,012 are held as treasury shares, leaving 8,906,391,636 ordinary shares with voting rights.
Material Changes and Programme Completion
This transaction marks the completion of the final tranche of the Buyback Programme announced on March 28, 2025. Since the start of the year, including shares purchased from Pfizer, Haleon has repurchased a total of 175,806,525 shares. Of this total, 131,372,271 shares were cancelled, and 44,434,254 shares were held as treasury shares prior to this latest purchase.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, revenue outlook, or management commentary on operational performance. It explicitly states that the announcement does not constitute an offer or solicitation of an offer for securities. No specific risks or contingencies are detailed in this report beyond standard regulatory disclosures.
Key Facts for Investor Verification
- Verify the total number of treasury shares held (45,962,012) against the company's latest balance sheet.
- Confirm the total number of voting shares (8,906,391,636) for disclosure threshold calculations under FCA rules.
- Review the full trade breakdown available via the provided RNS link for granular transaction data.
- Note that the filing contains no revenue, profit, or cash flow data; these metrics are not reported in this specific 6-K.